USANA Health Sciences Inc (USNA)
Official siteCONSUMER DEFENSIVE • PACKAGED FOODS • NYSE
Market Cap: $250.34M
Last updated: Nov 17, 2026 at 4:15 PM ET
USANA Health Sciences Inc (USNA) Statistics
USANA Health Sciences (USNA) has a market cap of $250.34M and an enterprise value of $71.42M. It holds $178.91M more cash than debt, 71.47% of its market cap.
Total Valuation
Enterprise value is 71.47% below the market cap, as cash exceeds debt.
| Market Cap | $250.34M |
|---|---|
| Enterprise Value | $71.42M |
| Latest price (Nov 17, 2026) | $13.60 |
Key Dates
The next earnings report is expected on Feb 10, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Feb 10, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 3, 2026 |
| Fiscal Year End | December |
Valuation Ratios
Sales and book value multiples are 0.3x and 0.5x. Its year-end P/E ranged from 10.2x to 23.0x from 2016 to 2025.
| P/E Ratio | 13.2x |
|---|---|
| Forward P/E | 24.2x |
| P/S Ratio | 0.3x |
| Forward P/S | 0.3x |
| P/B Ratio | 0.5x |
| P/TBV Ratio | 0.8x |
| P/FCF Ratio | 8.5x |
| P/OCF Ratio | 6.0x |
Enterprise Valuation
Counting debt and cash, the company is valued at 2.1x EBITDA and 2.5x free cash flow.
| EV / EBITDA | 2.1x |
|---|---|
| EV / EBIT | 210.7x |
| EV / FCF | 2.5x |
Price Statistics
The stock is down 29.13% over 52 weeks and trades 5.82% below its 50-day average.
| Beta (1Y) | 0.72 |
|---|---|
| 52-Week Change | -29.13% |
| 1-Month Change | -8.66% |
| 3-Month Change | +2.64% |
| 6-Month Change | -22.15% |
| 5-Year Change | -85.26% |
| 10-Year Change | -77.73% |
| Total Return (1Y) | -29.13% |
| Total Return (3Y CAGR) | -33.42% |
| Total Return (5Y CAGR) | -33.20% |
| Return vs SPY (1Y) | -39.06% |
| Max Drawdown (1Y) | -45.22% |
| Max Drawdown (3Y) | -76.62% |
| Sharpe Ratio (1Y) | -0.55 |
| Correlation with SPY (1Y) | 0.17 |
| 50-Day Average | $14.44 |
| 200-Day Average | $17.61 |
| 52-Week Range | $12.53 to $23.59 |
| RSI (14 Days) | 44.7 |
| Average Volume (20 Days) | 206.09K |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 2.59x current liabilities, and total debt is 0.00x shareholder equity.
| Current Ratio | 2.59x |
|---|---|
| Quick Ratio | 1.84x |
| Debt / Equity | 0.00x |
| Interest Coverage | 50.32x |
Returns and Efficiency
Return on equity is -4.02% over the last 12 months, against a 5-year average of 13.64%.
| Return on Equity (ROE) | -4.02% |
|---|---|
| Return on Assets (ROA) | -2.99% |
| Return on Capital Employed (ROCE) | 0.06% |
| ROE (5Y Average) | 13.64% |
| ROA (5Y Average) | 9.79% |
| ROIC (5Y Average) | 14.27% |
| Asset Turnover | 1.26x |
| Inventory Turnover | 2.42x |
| Receivables Turnover | 216.57x |
| Cash Conversion Cycle | 123 days |
Scores
USNA has an Altman Z-Score of 3.55, in the safe zone above 2.99, and a Piotroski F-Score of 6 of 9, in the average band of 3 to 7.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | 3.55 |
|---|---|
| Altman Z Zone | Safe |
| Piotroski F-Score | 6 of 9 |
| Piotroski Strength | Average |
Income Statement
Revenue of $905.58M over the last 12 months is down 0.78% from the 12 months before.
| Revenue | $905.58M |
|---|---|
| Revenue Growth (YoY) | -0.78% |
| Gross Profit | $699.68M |
| Operating Income | $9.68M |
| Pretax Income | -$62.00K |
| Net Income | -$21.20M |
| EBITDA | $34.80M |
| EBIT | $339.00K |
| Reported EPS (TTM) | $1.03 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 74.35% of the $708.47M in total assets.
| Cash and Equivalents | $178.91M |
|---|---|
| Total Debt | $0 |
| Net Cash | $178.91M |
| Net Cash Per Share | $9.67 |
| Working Capital | $177.99M |
| Shareholder Equity | $526.76M |
| Book Value Per Share | $28.48 |
| Tangible Book Value | $297.09M |
| Tangible Book Per Share | $16.06 |
| Total Assets | $708.47M |
| Total Liabilities | $138.38M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $12.12M of capital spending, operating cash flow left $29.54M of free cash flow.
| Operating Cash Flow | $41.65M |
|---|---|
| Capital Expenditures | $12.12M |
| Free Cash Flow | $29.54M |
| FCF Per Share | $1.60 |
| Depreciation and Amortization | $34.35M |
Trailing 12 months through Sep 30, 2026.
Margins
The operating margin is 1.07%, against a 5-year average of 9.70%.
| Gross Margin | 77.26% |
|---|---|
| Operating Margin | 1.07% |
| Pretax Margin | -0.01% |
| Net Margin | -2.34% |
| EBITDA Margin | 3.84% |
| EBIT Margin | 0.04% |
| FCF Margin | 3.26% |
| Gross Margin (5Y Average) | 79.88% |
| Operating Margin (5Y Average) | 9.70% |
| Net Margin (5Y Average) | 5.95% |
Growth
Revenue fell 2.51% a year over 3 years, and EPS 18.83% a year.
| Revenue Growth (3Y CAGR) | -2.51% |
|---|---|
| Revenue Growth (5Y CAGR) | -4.00% |
| EPS Growth (3Y CAGR) | -18.83% |
| EPS Growth (5Y CAGR) | -20.00% |
| FCF Growth (3Y CAGR) | -54.99% |
| FCF Growth (5Y CAGR) | -43.29% |
| Operating Income Growth (3Y CAGR) | -22.11% |
| Book Value Per Share Growth (2Y CAGR) | +6.20% |
| Tangible Book Per Share Growth (2Y CAGR) | -21.76% |
Dividends and Yields
USNA does not pay a dividend. Its free cash flow yield is 11.74%.
| Earnings Yield | 7.58% |
|---|---|
| FCF Yield | 11.74% |
| Shareholder Yield | 0.00% |
Stock Splits
The last split was a 2-for-1 forward split on Nov 23, 2016.
| Last Split Date | Nov 23, 2016 |
|---|---|
| Split Type | Forward split |
| Split Ratio | 2:1 |
Peer Position
Against 7 similar companies, USNA has the 4th highest P/E.
P/E RatioPeer median 12.7x
P/S RatioPeer median 0.6x
Revenue Growth (Trailing 4 Quarters, YoY)Peer median +11.44%
| P/E Ratio | 13.2x vs 12.7x median |
|---|---|
| P/S Ratio | 0.3x vs 0.6x median |
| Revenue Growth (Trailing 4 Quarters, YoY) | -0.78% vs +11.44% median |
Analyst Forecast
Consensus estimates put revenue growth at -0.45% and EPS growth at -19.31% a year over the next 2 fiscal years.
| Revenue Growth Forecast (2Y CAGR) | -0.45% |
|---|---|
| EPS Growth Forecast (2Y CAGR) | -19.31% |
Price Target
Analyst price targets are part of paid GNG plans. See plans
GNG Valuation
| GNG view | Undervalued |
|---|
GNG fair value is part of GNG Pro. See plans
Frequently Asked Questions About USNA
What is USNA's market cap?
USANA Health Sciences has a market cap of $250.34M. Its enterprise value, which adds debt and subtracts cash, is $71.42M.
What is USNA's P/E ratio?
USANA Health Sciences has a trailing P/E ratio of 13.2x and a forward P/E of 24.2x.
How many shares of USNA are outstanding?
USANA Health Sciences has 18.50M shares outstanding. The count is up 1.12% from a year earlier.
Does USNA pay a dividend?
No. USANA Health Sciences does not pay a dividend.
How much debt does USNA have?
USANA Health Sciences has $0 of total debt and $178.91M of cash and equivalents, a net cash position of $178.91M.
USNA pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors